Studies have found that the dysregulation of the Notch signaling pathway in human GC and the increased levels of Notch 1 and Jagged 1 are associated with the incidence of GC (Demitrack & Samuelson, 2017), but the mechanism of the Notch signaling pathway in GC remains unclear. The gene discussed is JAG1; the disease is gastric cancer.